Power Law company profile

Madrigal Pharmaceuticals

Biotech & Life Sciences · West Conshohocken, United States · Founded 2011 · IPO 2016 Unicorn

The Company is targeting treatment of both niche and prevalent indications, including fatty liver disease

Valuation

$11B

Market cap · May/2026

Revenue

$287M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

1 investor on Madrigal Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 1 investor entered at this stage

Bay City Capital

Global footprint

Where Madrigal Pharmaceuticals has talent and traffic

AI talent share

0.4% of workforce is AI talent
(4 of 1,071 staff)

Core AI30.28%

Other AI10.09%

Non-AI workforce1,06799.63%

Workforce by country

10 countries with
team presence

🇺🇸 United States92.3%

🇨🇭 Switzerland2.8%

🇩🇪 Germany2.5%

🇬🇧 United Kingdom0.7%

🇮🇹 Italy0.6%

Top 5 of 10 shown

Web traffic by country

140K monthly visits
across markets

🇺🇸 United States90.3%

🇬🇧 United Kingdom1.6%

🇨🇦 Canada1.4%

🇮🇳 India1.4%

🇯🇵 Japan0.9%

Top 5 markets shown

Patent intelligence

$37M patent portfolio · 53 active families

Estimated portfolio value

$37M

0.33% of market cap · 14.3× smaller than top peer ChemoCentryx ($524M)

53 active patent families

Where Madrigal Pharmaceuticals innovates DiseaseProdrugStructural formulaMedicinal chemistryInflammation

Where Madrigal Pharmaceuticals concentrates vs peers

Each axis is a top-10 topic across Madrigal Pharmaceuticals and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Madrigal Pharmaceuticals

An AI-synthesized read of the highest-engagement posts about Madrigal Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Madrigal Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles